HRP20090679T1 - Upotreba oksikodona za liječenje organske boli - Google Patents
Upotreba oksikodona za liječenje organske boli Download PDFInfo
- Publication number
- HRP20090679T1 HRP20090679T1 HR20090679T HRP20090679T HRP20090679T1 HR P20090679 T1 HRP20090679 T1 HR P20090679T1 HR 20090679 T HR20090679 T HR 20090679T HR P20090679 T HRP20090679 T HR P20090679T HR P20090679 T1 HRP20090679 T1 HR P20090679T1
- Authority
- HR
- Croatia
- Prior art keywords
- pain
- oxycodone
- pharmaceutically acceptable
- acceptable salt
- use according
- Prior art date
Links
- BRUQQQPBMZOVGD-XFKAJCMBSA-N Oxycodone Chemical compound O=C([C@@H]1O2)CC[C@@]3(O)[C@H]4CC5=CC=C(OC)C2=C5[C@@]13CCN4C BRUQQQPBMZOVGD-XFKAJCMBSA-N 0.000 title claims abstract 22
- 229960002085 oxycodone Drugs 0.000 title claims abstract 22
- 208000009935 visceral pain Diseases 0.000 title 1
- 150000003839 salts Chemical class 0.000 claims abstract 24
- 239000003814 drug Substances 0.000 claims abstract 16
- 208000002193 Pain Diseases 0.000 claims abstract 12
- 238000004519 manufacturing process Methods 0.000 claims abstract 5
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 claims 18
- 229940079593 drug Drugs 0.000 claims 11
- 229960005181 morphine Drugs 0.000 claims 9
- 239000002552 dosage form Substances 0.000 claims 4
- 239000004925 Acrylic resin Substances 0.000 claims 2
- 229920000178 Acrylic resin Polymers 0.000 claims 2
- 208000005171 Dysmenorrhea Diseases 0.000 claims 2
- 208000000112 Myalgia Diseases 0.000 claims 2
- 230000003187 abdominal effect Effects 0.000 claims 2
- 238000009472 formulation Methods 0.000 claims 2
- 239000011159 matrix material Substances 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 208000013465 muscle pain Diseases 0.000 claims 2
- 208000004998 Abdominal Pain Diseases 0.000 claims 1
- 206010000087 Abdominal pain upper Diseases 0.000 claims 1
- 206010003011 Appendicitis Diseases 0.000 claims 1
- 206010004663 Biliary colic Diseases 0.000 claims 1
- 208000019399 Colonic disease Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- 208000015877 Duodenal disease Diseases 0.000 claims 1
- 206010013935 Dysmenorrhoea Diseases 0.000 claims 1
- 208000037767 Gallbladder pain Diseases 0.000 claims 1
- 206010019705 Hepatic pain Diseases 0.000 claims 1
- 208000007914 Labor Pain Diseases 0.000 claims 1
- 208000035945 Labour pain Diseases 0.000 claims 1
- 206010033645 Pancreatitis Diseases 0.000 claims 1
- 206010035623 Pleuritic pain Diseases 0.000 claims 1
- 208000004550 Postoperative Pain Diseases 0.000 claims 1
- 206010038490 Renal pain Diseases 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 230000002183 duodenal effect Effects 0.000 claims 1
- 208000018595 duodenum disease Diseases 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 238000013265 extended release Methods 0.000 claims 1
- 238000000338 in vitro Methods 0.000 claims 1
- 208000002551 irritable bowel syndrome Diseases 0.000 claims 1
- 239000008024 pharmaceutical diluent Substances 0.000 claims 1
- 210000000813 small intestine Anatomy 0.000 claims 1
- 238000001356 surgical procedure Methods 0.000 claims 1
- 238000013268 sustained release Methods 0.000 claims 1
- 239000012730 sustained-release form Substances 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64549005P | 2005-01-18 | 2005-01-18 | |
| PCT/EP2006/050252 WO2006077212A1 (en) | 2005-01-18 | 2006-01-17 | Use of oxycodone for treating visceral pain |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20090679T1 true HRP20090679T1 (hr) | 2010-01-31 |
Family
ID=35871217
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20090679T HRP20090679T1 (hr) | 2005-01-18 | 2009-12-18 | Upotreba oksikodona za liječenje organske boli |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US20080200493A1 (zh) |
| EP (1) | EP1838318B1 (zh) |
| JP (1) | JP5049139B2 (zh) |
| KR (10) | KR20200128451A (zh) |
| CN (1) | CN101106996B (zh) |
| AP (1) | AP2249A (zh) |
| AR (1) | AR052880A1 (zh) |
| AT (2) | ATE446092T1 (zh) |
| AU (1) | AU2006207498B2 (zh) |
| BR (1) | BRPI0606247A2 (zh) |
| CA (1) | CA2595043C (zh) |
| CY (1) | CY1109660T1 (zh) |
| DE (2) | DE602006009899D1 (zh) |
| DK (2) | DK1838318T3 (zh) |
| EA (1) | EA013544B1 (zh) |
| ES (1) | ES2333901T3 (zh) |
| HK (1) | HK1107933A1 (zh) |
| HR (1) | HRP20090679T1 (zh) |
| IL (1) | IL184530A (zh) |
| ME (1) | ME01066B (zh) |
| MX (1) | MX2007007207A (zh) |
| MY (1) | MY144471A (zh) |
| NO (1) | NO338968B1 (zh) |
| NZ (1) | NZ555852A (zh) |
| PL (1) | PL1838318T3 (zh) |
| PT (1) | PT1838318E (zh) |
| RS (1) | RS51069B (zh) |
| SI (1) | SI1838318T1 (zh) |
| TW (1) | TWI432196B (zh) |
| UA (1) | UA85471C2 (zh) |
| WO (1) | WO2006077212A1 (zh) |
| ZA (1) | ZA200705231B (zh) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AP2008004467A0 (en) | 2005-11-14 | 2008-06-30 | Rinat Neurosciene Corp | Antagonist antibodies directed against calcitonin generelated peptide anf methods using same |
| CA2687192C (en) | 2007-06-04 | 2015-11-24 | Egalet A/S | Controlled release pharmaceutical compositions for prolonged effect |
| BRPI0907135B8 (pt) | 2008-03-04 | 2021-05-25 | Labrys Biologics Inc | uso de um anticorpo antagonista anti-cgrp para a prevenção e/ou tratamento de dor de câncer crônica |
| EP2393484A1 (en) | 2009-02-06 | 2011-12-14 | Egalet Ltd. | Immediate release composition resistant to abuse by intake of alcohol |
| AU2010265213B2 (en) | 2009-06-24 | 2012-08-23 | Egalet Ltd. | Controlled release formulations |
| AU2010288194B2 (en) | 2009-08-28 | 2013-08-29 | Teva Pharmaceuticals International Gmbh | Methods for treating visceral pain by administering antagonist antibodies directed against calcitonin gene-related peptide |
| DK2710039T3 (en) | 2011-05-20 | 2019-04-01 | Alderbio Holdings Llc | ANTI-CGRP COMPOSITIONS AND APPLICATION THEREOF |
| SG194973A1 (en) | 2011-05-20 | 2013-12-30 | Alderbio Holdings Llc | Use of anti-cgrp antibodies and antibody fragments to prevent or inhibit photophobia or light aversion in subjects in need thereof, especially migraine sufferers |
| EP2709662B1 (en) | 2011-05-20 | 2019-07-31 | AlderBio Holdings LLC | Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| MX2016012188A (es) | 2014-03-21 | 2017-04-27 | Teva Pharmaceuticals Int Gmbh | Anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de calcitonina y metodos que usan los mismos. |
| JP6937368B2 (ja) | 2016-09-23 | 2021-09-22 | テバ・ファーマシューティカルズ・インターナショナル・ゲー・エム・ベー・ハー | 難治性片頭痛の治療方法 |
| KR20210094513A (ko) | 2018-11-19 | 2021-07-29 | 재즈 파마슈티칼즈 아일랜드 리미티드 | 알코올-내성 약물 제형 |
| CR20210373A (es) | 2019-01-08 | 2021-08-19 | H Lundbeck As | Tratamiento agudo y tratamiento rápido de la cefalea usando anticuerpos anti-cgrp |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5656295A (en) * | 1991-11-27 | 1997-08-12 | Euro-Celtique, S.A. | Controlled release oxycodone compositions |
| US5958459A (en) * | 1991-12-24 | 1999-09-28 | Purdue Pharma L.P. | Opioid formulations having extended controlled released |
| US5968551A (en) * | 1991-12-24 | 1999-10-19 | Purdue Pharma L.P. | Orally administrable opioid formulations having extended duration of effect |
| US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| IL110014A (en) * | 1993-07-01 | 1999-11-30 | Euro Celtique Sa | Solid controlled-release oral dosage forms of opioid analgesics |
| US5965161A (en) * | 1994-11-04 | 1999-10-12 | Euro-Celtique, S.A. | Extruded multi-particulates |
| NZ332039A (en) * | 1996-03-25 | 2000-06-23 | Lilly Co Eli | Method for treating pain using olanzapine and NSAIDs |
| UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
| US6992193B2 (en) * | 2003-06-10 | 2006-01-31 | Adolor Corporation | Sulfonylamino phenylacetamide derivatives and methods of their use |
-
2006
- 2006-01-05 TW TW095100458A patent/TWI432196B/zh not_active IP Right Cessation
- 2006-01-09 MY MYPI20060082A patent/MY144471A/en unknown
- 2006-01-17 KR KR1020207031796A patent/KR20200128451A/ko not_active Application Discontinuation
- 2006-01-17 CA CA2595043A patent/CA2595043C/en active Active
- 2006-01-17 KR KR1020127011713A patent/KR20120089710A/ko not_active Application Discontinuation
- 2006-01-17 DE DE602006009899T patent/DE602006009899D1/de active Active
- 2006-01-17 UA UAA200708142A patent/UA85471C2/ru unknown
- 2006-01-17 KR KR1020197035201A patent/KR20190135557A/ko not_active Application Discontinuation
- 2006-01-17 KR KR1020177004572A patent/KR20170021905A/ko not_active Application Discontinuation
- 2006-01-17 ES ES06700652T patent/ES2333901T3/es active Active
- 2006-01-17 KR KR1020227041445A patent/KR20220165797A/ko not_active Application Discontinuation
- 2006-01-17 US US11/814,020 patent/US20080200493A1/en not_active Abandoned
- 2006-01-17 DK DK06700652T patent/DK1838318T3/da active
- 2006-01-17 JP JP2007550797A patent/JP5049139B2/ja not_active Expired - Fee Related
- 2006-01-17 EP EP06700652A patent/EP1838318B1/en active Active
- 2006-01-17 KR KR1020077018905A patent/KR20070100368A/ko not_active Application Discontinuation
- 2006-01-17 MX MX2007007207A patent/MX2007007207A/es active IP Right Grant
- 2006-01-17 KR KR1020087029312A patent/KR20080106991A/ko active Application Filing
- 2006-01-17 NZ NZ555852A patent/NZ555852A/en unknown
- 2006-01-17 SI SI200630538T patent/SI1838318T1/sl unknown
- 2006-01-17 RS RSP-2009/0553A patent/RS51069B/sr unknown
- 2006-01-17 ME MEP-2009-352A patent/ME01066B/me unknown
- 2006-01-17 KR KR1020147018838A patent/KR20140091782A/ko not_active Application Discontinuation
- 2006-01-17 PL PL06700652T patent/PL1838318T3/pl unknown
- 2006-01-17 DE DE202006019887U patent/DE202006019887U1/de not_active Expired - Lifetime
- 2006-01-17 AT AT06700652T patent/ATE446092T1/de active
- 2006-01-17 KR KR1020217034339A patent/KR20210131450A/ko not_active Application Discontinuation
- 2006-01-17 PT PT06700652T patent/PT1838318E/pt unknown
- 2006-01-17 CN CN2006800024739A patent/CN101106996B/zh active Active
- 2006-01-17 EA EA200701541A patent/EA013544B1/ru not_active IP Right Cessation
- 2006-01-17 AU AU2006207498A patent/AU2006207498B2/en active Active
- 2006-01-17 AP AP2007004057A patent/AP2249A/xx active
- 2006-01-17 BR BRPI0606247-4A patent/BRPI0606247A2/pt not_active Application Discontinuation
- 2006-01-17 WO PCT/EP2006/050252 patent/WO2006077212A1/en active Application Filing
- 2006-01-17 KR KR1020237042001A patent/KR20230170811A/ko active Application Filing
- 2006-01-18 AR ARP060100177A patent/AR052880A1/es unknown
-
2007
- 2007-03-09 AT AT0014807U patent/AT9895U1/de not_active IP Right Cessation
- 2007-07-02 ZA ZA200705231A patent/ZA200705231B/xx unknown
- 2007-07-10 IL IL184530A patent/IL184530A/en active IP Right Grant
- 2007-07-24 DK DK200700207U patent/DK200700207U3/da not_active IP Right Cessation
- 2007-08-14 NO NO20074174A patent/NO338968B1/no not_active IP Right Cessation
- 2007-12-12 HK HK07113550.8A patent/HK1107933A1/xx unknown
-
2009
- 2009-12-16 CY CY20091101308T patent/CY1109660T1/el unknown
- 2009-12-18 HR HR20090679T patent/HRP20090679T1/hr unknown
-
2014
- 2014-10-15 US US14/515,216 patent/US9271974B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20090679T1 (hr) | Upotreba oksikodona za liječenje organske boli | |
| Edaravone Acute Infarction Study Group | Effect of a novel free radical scavenger, edaravone (MCI-186), on acute brain infarction. Randomized, placebo-controlled, double-blind study at multicenters | |
| RU2404750C2 (ru) | Композиция, содержащая основу или покрытие для замедленного высвобождения и антагонист nmda рецептора, способ введения такого nmda антагониста субъекту | |
| JP2008526927A5 (zh) | ||
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| RU2007132181A (ru) | ПРОТИВОРАКОВОЕ ЛЕКАРСТВЕННОЕ СРЕДСТВО, СОДЕРЖАЩЕЕ α,α,α-ТРИФТОРТИМИДИН И ИНГИБИТОР ТИМИДИНФОСФОРИЛАЗЫ | |
| RU2011110765A (ru) | Фармацевтическая композиция энтакапона или его солей пролонгрированного высвобождения | |
| CN102204904B (zh) | 左旋奥拉西坦在制备预防或治疗认知功能障碍药物中的应用 | |
| JP2019517542A5 (zh) | ||
| HRP20230272T1 (hr) | Postupci za liječenje cistične fibroze | |
| JP2007302657A (ja) | 痙症の兆候および症候の緩和方法 | |
| RU2008102911A (ru) | Фармацевтические составы на основе гуанфацина, подходящие для ежедневного введения в виде единичной дозированной формы | |
| JP2018507243A5 (zh) | ||
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
| BR112013010829B1 (pt) | Omposição farmacêutica intravenosa para proporcionar alívio da dor e/ou da inflamação | |
| JP2001510795A5 (zh) | ||
| WO2007120485A2 (en) | Methods of treating pain with alkylxanthines and antiepileptics and compositions for use therefor | |
| JPS59193821A (ja) | 抗不安薬としてのフルオキセチンの使用法 | |
| NO20080244L (no) | Doseringsstyring for prasugrel | |
| RU2007101695A (ru) | Лекарственный препарат для лечения сахарного диабета на основе экзенатида и даларгина, применение и способ лечения | |
| AU2018357350B2 (en) | Delayed release deferiprone tablets and methods of using the same | |
| RU2261098C2 (ru) | Перорально распадающаяся композиция, содержащая миртазапин | |
| CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
| ES2668943T3 (es) | Composición farmacéutica para tratar eyaculación precoz y método de tratamiento de la eyaculación precoz |